NO964567L - Våtgranuleringsformulering for bisfosfonsyrer - Google Patents
Våtgranuleringsformulering for bisfosfonsyrerInfo
- Publication number
- NO964567L NO964567L NO964567A NO964567A NO964567L NO 964567 L NO964567 L NO 964567L NO 964567 A NO964567 A NO 964567A NO 964567 A NO964567 A NO 964567A NO 964567 L NO964567 L NO 964567L
- Authority
- NO
- Norway
- Prior art keywords
- wet granulation
- bisphosphonic acids
- binder
- prepared
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23690494A | 1994-04-29 | 1994-04-29 | |
PCT/US1995/004965 WO1995029679A1 (en) | 1994-04-29 | 1995-04-24 | Wet granulation formulation for bisphosphonic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964567D0 NO964567D0 (no) | 1996-10-28 |
NO964567L true NO964567L (no) | 1996-10-28 |
Family
ID=22891482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964567A NO964567L (no) | 1994-04-29 | 1996-10-28 | Våtgranuleringsformulering for bisfosfonsyrer |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP0756484B1 (ko) |
JP (1) | JP3838658B2 (ko) |
KR (1) | KR100390719B1 (ko) |
CN (2) | CN1781489A (ko) |
AT (1) | ATE225661T1 (ko) |
AU (1) | AU694217C (ko) |
BG (1) | BG62878B1 (ko) |
CA (1) | CA2188567C (ko) |
CO (1) | CO4560546A1 (ko) |
CZ (1) | CZ291574B6 (ko) |
DE (1) | DE69528525T2 (ko) |
DK (1) | DK0756484T3 (ko) |
ES (1) | ES2183873T3 (ko) |
FI (1) | FI118206B (ko) |
HK (1) | HK1009246A1 (ko) |
HR (1) | HRP950261B1 (ko) |
HU (1) | HUT76297A (ko) |
IL (1) | IL113465A (ko) |
LV (1) | LV13114B (ko) |
MX (1) | MX9605222A (ko) |
MY (1) | MY120491A (ko) |
NO (1) | NO964567L (ko) |
NZ (1) | NZ284719A (ko) |
PL (1) | PL316987A1 (ko) |
PT (1) | PT756484E (ko) |
RU (1) | RU2149003C1 (ko) |
SA (1) | SA95160013B1 (ko) |
SK (1) | SK283785B6 (ko) |
TW (1) | TW390813B (ko) |
UA (1) | UA44733C2 (ko) |
WO (1) | WO1995029679A1 (ko) |
YU (1) | YU49458B (ko) |
ZA (1) | ZA953437B (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
DE19719680A1 (de) | 1997-05-09 | 1998-11-19 | Boehringer Mannheim Gmbh | Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz |
AU729912B2 (en) * | 1997-06-11 | 2001-02-15 | Warner Chilcott Company, Llc | Film-coated tablet for improved upper gastrointestinal tract safety |
IL121623A (en) * | 1997-08-26 | 2000-06-29 | Unipharm Ltd | Process for the preparation of solid oral dosage forms comprising alendronic acid |
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
EP0998933A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
WO2000071104A2 (en) * | 1999-05-21 | 2000-11-30 | Novartis Ag | Use of bisphosphonic acids for treating angiogenesis |
PL196485B1 (pl) * | 2000-05-11 | 2008-01-31 | Inst Farmaceutyczny | Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania |
GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
ES2532393T3 (es) | 2002-05-10 | 2015-03-26 | F. Hoffmann-La Roche Ag | Acidos bisfosfónicos para tratamiento y prevención de osteoporosis |
NZ536273A (en) † | 2002-12-20 | 2007-08-31 | Hoffmann La Roche | High dose ibandronate formulation |
JP4608488B2 (ja) * | 2003-07-11 | 2011-01-12 | エフ.ホフマン−ラ ロシュ アーゲー | メシル酸サキナビル経口投与剤型 |
CA2631492A1 (en) * | 2005-12-15 | 2007-06-21 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
CN101489563A (zh) * | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
KR102622198B1 (ko) * | 2018-03-30 | 2024-01-09 | 한미약품 주식회사 | 빌다글립틴을 함유하는 경구용 고형제제 및 그의 제조 방법 |
CN112972400A (zh) * | 2021-03-09 | 2021-06-18 | 华侨大学 | 可快速崩解的米诺膦酸颗粒及制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
US4711886A (en) * | 1984-07-02 | 1987-12-08 | Merck & Co., Inc. | β-lactam derivatives as anti-inflammatory and antidegenerative agents |
US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
US4973576A (en) * | 1987-03-10 | 1990-11-27 | Yamanouchi Pharmaceutical Co., Ltd. | Bisphophonic acid derivatives and pharmaceutical compositions containing the same |
FR2629716B1 (fr) * | 1988-04-07 | 1991-07-19 | Sanofi Sa | Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
FI89366C (fi) * | 1990-12-20 | 1993-09-27 | Leiras Oy | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat |
TW237386B (ko) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
SE501389C2 (sv) * | 1992-04-24 | 1995-01-30 | Leiras Oy | Farmaceutiskt preparat och förfarande för dess framställning |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
FR2703590B1 (fr) * | 1993-04-05 | 1995-06-30 | Sanofi Elf | Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse . |
-
1995
- 1995-04-21 TW TW084103960A patent/TW390813B/zh not_active IP Right Cessation
- 1995-04-24 DE DE69528525T patent/DE69528525T2/de not_active Expired - Fee Related
- 1995-04-24 PT PT95917120T patent/PT756484E/pt unknown
- 1995-04-24 SK SK1390-96A patent/SK283785B6/sk not_active IP Right Cessation
- 1995-04-24 UA UA96104062A patent/UA44733C2/uk unknown
- 1995-04-24 HU HU9602986A patent/HUT76297A/hu unknown
- 1995-04-24 ES ES95917120T patent/ES2183873T3/es not_active Expired - Lifetime
- 1995-04-24 KR KR1019960705995A patent/KR100390719B1/ko not_active IP Right Cessation
- 1995-04-24 MX MX9605222A patent/MX9605222A/es not_active IP Right Cessation
- 1995-04-24 NZ NZ284719A patent/NZ284719A/en not_active IP Right Cessation
- 1995-04-24 JP JP52830795A patent/JP3838658B2/ja not_active Expired - Fee Related
- 1995-04-24 PL PL95316987A patent/PL316987A1/xx unknown
- 1995-04-24 CZ CZ19963152A patent/CZ291574B6/cs not_active IP Right Cessation
- 1995-04-24 CA CA002188567A patent/CA2188567C/en not_active Expired - Fee Related
- 1995-04-24 CN CNA2005100894927A patent/CN1781489A/zh active Pending
- 1995-04-24 AU AU23939/95A patent/AU694217C/en not_active Ceased
- 1995-04-24 WO PCT/US1995/004965 patent/WO1995029679A1/en active IP Right Grant
- 1995-04-24 DK DK95917120T patent/DK0756484T3/da active
- 1995-04-24 CN CN95192826A patent/CN1147202A/zh active Pending
- 1995-04-24 EP EP95917120A patent/EP0756484B1/en not_active Expired - Lifetime
- 1995-04-24 RU RU96120154A patent/RU2149003C1/ru active
- 1995-04-24 IL IL11346595A patent/IL113465A/xx not_active IP Right Cessation
- 1995-04-24 AT AT95917120T patent/ATE225661T1/de not_active IP Right Cessation
- 1995-04-26 MY MYPI95001074A patent/MY120491A/en unknown
- 1995-04-27 CO CO95017550A patent/CO4560546A1/es unknown
- 1995-04-28 HR HR950261A patent/HRP950261B1/xx not_active IP Right Cessation
- 1995-04-28 ZA ZA953437A patent/ZA953437B/xx unknown
- 1995-04-28 YU YU27395A patent/YU49458B/sh unknown
- 1995-05-31 SA SA95160013A patent/SA95160013B1/ar unknown
-
1996
- 1996-10-16 BG BG100911A patent/BG62878B1/bg unknown
- 1996-10-25 FI FI964315A patent/FI118206B/fi active IP Right Grant
- 1996-10-28 NO NO964567A patent/NO964567L/no unknown
-
1998
- 1998-08-12 HK HK98109861A patent/HK1009246A1/xx not_active IP Right Cessation
-
2003
- 2003-10-08 LV LVP-03-109A patent/LV13114B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964567D0 (no) | Våtgranuleringsformulering for bisfosfonsyrer | |
CA2149052A1 (en) | Dry mix formulation for bisphosphonic acids | |
HUP0204114A2 (hu) | Bifoszfonáttartalmú parenterális gyógyászati készítmény | |
HK1072539A1 (en) | Use of bisphosphonates in the preparation of a medicament for the treatment of conditings of abnormally increased bone turnover | |
TR199800767T2 (xx) | Proteaz engelleyicileri. | |
NZ332314A (en) | Oral pharmaceutical preparation containing ibandronate or salts thereof in the form of an inner section containing the active ingredient surrounded by a coating free of the active ingredient | |
NZ515541A (en) | Pharmaceutical compositions comprising bisphosphonates to treat angiogenesis | |
CA2024694A1 (en) | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors | |
CA2035179A1 (en) | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids | |
WO2004058235A3 (en) | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative | |
EP0341961A3 (en) | Polymalonic acids as boneaffinity agents | |
BR9808233A (pt) | Preparação farmacêutica | |
ATE330616T1 (de) | Verabreichung von bisphosphonaten durch inhalation zur behandlung von knochenresorption und osteoporosis | |
IS1801B (is) | Pýridýlbisfosfónöt til notkunar sem efni til lækninga | |
ES2152865A1 (es) | Utilizacion de bisfosfonatos en la preparacion de composiciones farmaceuticas para uso intramuscular. | |
BR0106601A (pt) | Composição farmacêutica contendo bisfosfonato para o tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato, seu uso na preparação de medicamento para o tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato, método de tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato | |
IL141218A0 (en) | Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption |